Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 24 for “"Pharmacogenetic Testing"”.

  1. HEALTH ECONOMICS OF PHARMACOGENETIC TESTING

    … FACTORS HAVE BEEN WELL ESTABLISHED, ADOPTION OF PHARMACOGENETIC TESTING TO REDUCE SJS RISK IN CLINICAL CARE HAS BEEN SLOW. I CONDUCT HEALTH ECONOMIC EVALUATIONS TO INFORM CLINICAL AND REGULATORY DECISION MAKING ON WHETHER PHARMACOGENETIC TESTING SHOULD BE DONE TO REDUCE THE RISK OF SJS IN …

    nus Repository record for HEALTH ECONOMICS OF PHARMACOGENETIC TESTING (opens in a new tab) Download file for HEALTH ECONOMICS OF PHARMACOGENETIC TESTING (opens in a new tab)

  2. Payer Perspectives On Preemptive Pharmacogenetic Testing

    Purpose: As preemptive pharmacogenetics expands in the academic healthcare setting, further study is needed to assess the views of additional stakeholders in the marketplace on this technology and the barriers and facilitators to their uptake. The purpose of this study is to investigate the …

    mississippi Repository record for Payer Perspectives On Preemptive Pharmacogenetic Testing (opens in a new tab)

  3. Pharmacogenetic testing in outpatient mental health clinics

    … health clinicians' perceived knowledge regarding pharmacogenetic testing; their attitude, receptivity towards, and confidence in pharmacogenetic testing; and how pharmacogenetic testing is being implemented to support decision making in outpatient clinics. This study was guided by Rogers' …

    missouri Repository record for Pharmacogenetic testing in outpatient mental health clinics (opens in a new tab)

  4. EQUITABLE PHARMACOGENETIC TESTING IMPLEMENTATION FOR RURAL AND UNDERSERVED POPULATIONS

    Pharmacogenetic testing has potential to transform healthcare, yet implementation strategies have been limited to major academic medical centers serving metropolitan communities and large health systems. In contrast, rural, community-based health systems are slow to implement these advances, …

    montana Repository record for EQUITABLE PHARMACOGENETIC TESTING IMPLEMENTATION FOR RURAL AND UNDERSERVED POPULATIONS (opens in a new tab)

  5. EQUITABLE PHARMACOGENETIC TESTING IMPLEMENTATION FOR RURAL AND UNDERSERVED POPULATIONS

    Pharmacogenetic testing has potential to transform healthcare, yet implementation strategies have been limited to major academic medical centers serving metropolitan communities and large health systems. In contrast, rural, community-based health systems are slow to implement these advances, …

    montana-tech Repository record for EQUITABLE PHARMACOGENETIC TESTING IMPLEMENTATION FOR RURAL AND UNDERSERVED POPULATIONS (opens in a new tab)

  6. HIV genomics : trends in antiretroviral resistance and future directions for pharmacogenetic testing

    … practices. Over the past two decades, genetic testing for HIV drug resistance has become an important tool for HIV care. Next generation massively parallel sequencing has proven to be a powerful sequencing tool rivaling the gold standard Sanger sequencing method, however it is not yet widely …

    ubc Repository record for HIV genomics : trends in antiretroviral resistance and future directions for pharmacogenetic testing (opens in a new tab) Download PDF for HIV genomics : trends in antiretroviral resistance and future directions for pharmacogenetic testing (opens in a new tab)

  7. An assessment of barriers to nurse practitioners’ utilizing pharmacogenetic testing for depression

    … is 60% (Alemi et al., 2021). Pharmacogenomic testing (PGT) is beneficial in disease management by determining individual genotype responses to specific medications. Incorporating PGT into routine care for depression can lessen the time it takes to reach disease remission as well as avoid any …

    ndsu Repository record for An assessment of barriers to nurse practitioners’ utilizing pharmacogenetic testing for depression (opens in a new tab)

  8. Depression Outcomes in Care Coordination, Primary Care and Psychiatry Patients After Pharmacogenetic Testing

    … outcomes of patient activation before and after pharmacogenetic care in a coordinated care population. The process of pharmacogenetic care includes the patient’s acknowledgment of medication changes which are based on their genetic profile. This study will be framed by Dorothea Orem’s Self-Care …

    sdstate Repository record for Depression Outcomes in Care Coordination, Primary Care and Psychiatry Patients After Pharmacogenetic Testing (opens in a new tab)

  9. Literacy, expectations, and satisfaction of psychiatric pharmacogenetic testing in youth receiving pharmacological treatment for a mental health condition

    Background: Pharmacogenetic (PGx) testing uses a person’s DNA to inform prescribing. Despite established clinical benefits, patient literacy, expectations, and satisfaction with PGx testing is unclear, particularly in youth. This study assessed literacy, expectations, and satisfaction of PGx …

    calgary Repository record for Literacy, expectations, and satisfaction of psychiatric pharmacogenetic testing in youth receiving pharmacological treatment for a mental health condition (opens in a new tab)

  10. Perspectives on the Application of Pharmacogenomics in Patient Care

    … in the clinical setting, through the use of pharmacogenetic testing, still has not gained widespread acceptance. This work describes multiple aspects of pharmacogenomics, which drive current research in this field. Chapter I is an introduction to pharmacogenomics. Regulatory agencies and …

    clemson Repository record for Perspectives on the Application of Pharmacogenomics in Patient Care (opens in a new tab)

  11. Understanding Exposure to Pharmacogenetically Actionable Opioids in Primary Care

    Pharmacogenetic testing has the potential to improve pain management through addressing wide interindividual variations in responses to pharmacogenetically actionable opioids, ultimately decreasing costly adverse drug effects and improving responses to these medications. A recent review of …

    iupui Repository record for Understanding Exposure to Pharmacogenetically Actionable Opioids in Primary Care (opens in a new tab)

  12. Overcoming barriers to the clinical implementation of pharmacogenomics : associations between UGT1A1*28 and irinotecan therapy clinical outcomes, and an exploration of the issues among hospital pharmacists

    Pharmacogenetic testing aims to personalise drug therapy by prescribing medications according to an individual's genetic predisposition to drug efficacy and toxicity. More accurately targeting drug therapy to individuals most likely to respond and least likely to have adverse effects will benefit …

    adelaide Repository record for Overcoming barriers to the clinical implementation of pharmacogenomics : associations between UGT1A1*28 and irinotecan therapy clinical outcomes, and an exploration of the issues among hospital pharmacists (opens in a new tab)

  13. Personalized medicine: examining the current and future applications of pharmacogenetics and pharmacogenomics

    … on the tumor genotype, the very definition of pharmacogenetic testing. More specifically, pharmacogenetics or pharmacogenomics is defined as variations in genes that can affect drug response. There has been great deal of research into pharmacogenetics and its potential fields for application. …

    bu Repository record for Personalized medicine: examining the current and future applications of pharmacogenetics and pharmacogenomics (opens in a new tab)

  14. Investigating and identifying genetic predictors for cisplatin-induced hearing loss and anthracycline-induced cardiotoxicity

    … enable development of a new CIHL predictive pharmacogenetic test that includes ACYP2 along with TPMT and recommend early pharmacogenetic testing to prevent CIHL. The additional genetic insight into ACT may also help improve the predictive ability of pharmacogenetic testing for ACT. This …

    ubc Repository record for Investigating and identifying genetic predictors for cisplatin-induced hearing loss and anthracycline-induced cardiotoxicity (opens in a new tab) Download PDF for Investigating and identifying genetic predictors for cisplatin-induced hearing loss and anthracycline-induced cardiotoxicity (opens in a new tab)

  15. Implementation of pharmacogenetic risk prediction models in pediatric oncology

    … Based on these clinical practice guidelines, pharmacogenetic risk prediction models that combined several genetic variants into one predicted outcome for anthracycline-induced cardiotoxicity and cisplatin-induced ototoxicity were developed using logistic regression. In this study, …

    ubc Repository record for Implementation of pharmacogenetic risk prediction models in pediatric oncology (opens in a new tab) Download PDF for Implementation of pharmacogenetic risk prediction models in pediatric oncology (opens in a new tab)

  16. Personalizing Colorectal Cancer Care: Opportunities for Pharmacogenomics

    … explores the opportunities for germline pharmacogenetic testing to inform chemotherapy and non-chemotherapy medication selection in a historical cohort of Americans with metastatic colorectal cancer and models the theoretical cost-effectiveness of implementing this approach.

    umn Repository record for Personalizing Colorectal Cancer Care: Opportunities for Pharmacogenomics (opens in a new tab)

  17. Tools and Challenges for the Implementation of Next-Generation Sequencing in Clinical Pharmacogenetics

    … an individual's response to therapeutic drugs (pharmacogenetics) is a unique area of research with significant translational impact for medicine. Known genetic variants with effects on important clinical phenotypes, including clopidogrel efficacy and warfarin maintenance dose, highlight the …

    washington Repository record for Tools and Challenges for the Implementation of Next-Generation Sequencing in Clinical Pharmacogenetics (opens in a new tab)

  18. Human host and malaria parasite genome variations to susceptibility to malaria

    … determine whether there are differences in the pharmacogenetic profiles when comparing populations residing in malaria endemic and non-endemic areas. Methodology: Genome-wide genotype datasets (n=13, 447) from four malaria endemic African populations, including Mali, Kenya, Gambia, and Malawi, …

    cape-town Repository record for Human host and malaria parasite genome variations to susceptibility to malaria (opens in a new tab)

  19. Functional validation of UGT1A6 in anthracycline-induced cardiotoxicity

    … of precision medicine can be achieved via pharmacogenetic testing prior to treatment onset thanks to the genomic revolution. It has allowed for large-scale genetic testing to be done relatively inexpensively resulting in specific genetic variants to be linked with a phenotype or disease of …

    ubc Repository record for Functional validation of UGT1A6 in anthracycline-induced cardiotoxicity (opens in a new tab) Download PDF for Functional validation of UGT1A6 in anthracycline-induced cardiotoxicity (opens in a new tab)

Page 1 of 2